home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Genetic News | search  
 

New Link Between Colorectal Cancer and a Signalling Protein Reported

 
  August, 28 2000 6:48
your information resource in human molecular genetics
 
     
NEW LIGHT ON BOWEL CANCER

Colorectal cancer is a particularly common form of cancer in the ageing human population. In this week's Nature [VOL. 406, NO. 6798, 24 AUGUST 2000, pp. 897-902)], Josef Penninger and his colleagues from the Ontario Cancer Institute, Canada, report on a new link between this disease and a signalling protein known as 'p110g' (which rejoices in the full name of 'the p110g catalytic subunit of phosphoinositide-3-OH kinase').

Mice that have been genetically engineered to lack p110g show an increased incidence of colorectal cancers, implying that under normal conditions p110g can act as a 'brake' on the development of this type of cancer. Indeed, p110g is absent from human colon cancer cells, and restoration of the protein into these cells suppresses tumorigenesis. Further analysis of the role that p110g plays in regulating colon cell growth may help develop treatments for this common condition, Penninger suggests.

CONTACT:

Josef Penninger
tel +1 416 204 2241/2236/2283,
fax +1 416 204 2278/500,
e-mail jpenning@amgen.com

(C) Nature press release.


Message posted by: Trevor M. D'Souza

print this article mail this article
Bookmark and Share this page (what is this?)

Social bookmarking allows users to save and categorise a personal collection of bookmarks and share them with others. This is different to using your own browser bookmarks which are available using the menus within your web browser.

Use the links below to share this article on the social bookmarking site of your choice.

Read more about social bookmarking at Wikipedia - Social Bookmarking

Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2016 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.